"10.1371_journal.pmed.0050157","plos medicine","2008-08-05T00:00:00Z","Martin Cranage; Sally Sharpe; Carolina Herrera; Alethea Cope; Mike Dennis; Neil Berry; Claire Ham; Jonathan Heeney; Naser Rezk; Angela Kashuba; Peter Anton; Ian McGowan; Robin Shattock","Centre for Infection, Division of Cellular & Molecular Medicine, St Georges University of London, London, United Kingdom; Centre for Emergency Preparedness and Response, Health Protection Agency, Porton Down, Salisbury, United Kingdom; Division of Retrovirology, National Institute for Biological Standards & Control, South Mimms, United Kingdom; Department of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands; Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom; University of North Carolina Centers for Aids Research (CFAR) Clinical Pharmacology and Analytical Chemistry Core, Chapel Hill, North Carolina, United States of America; Center for Prevention Research, David Geffen School of Medicine at the University of California Los Angeles (UCLA), Los Angeles, California, United States of America","MC, SS, and RS designed the experiments; SS and MD were responsible for the in vivo work; C. Herrera performed the explant experiments; AC performed the ELISpot experiments; NB, C. Ham, and JH performed the quantitative PCR analyses; NR and AK were responsible for the assay of tenofovir; PA coordinated the overall Microbicide Development Programme; IMcG had oversight of the preclinical testing project; and MC wrote the manuscript.","The authors declare no competing financial interests.","2008","08","Martin Cranage","MC",13,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
